Clinical Research
corporate_fare

Universita' Degli Studi Di Napoli Federico II

Address
Via Sergio Pansini 5

Sponsor Overview

assignment
3
sponsored trials
science
3
molecules
location_city
4
research centres
public
1
country
person_search
6
investigators

Specializations

Cardiovascular medicine

Research activity includes acute myocardial infarction in patients with ST-elevation myocardial infarction and multivessel disease, with attention to coronary microcirculation and microvascular dysfunction.

  • Myocardial infarction
  • Coronary microcirculation
  • Microvascular dysfunction

The cardiovascular portfolio also reflects interest in inflammatory biomarkers and endothelial function in cardiometabolic disease.

Neurogenetic disorders

Clinical research extends to Friedreich's ataxia, with focus on FXN transcription and frataxin protein biology.

  • Friedreich's ataxia
  • FXN transcription
  • Frataxin protein

This area places emphasis on molecular mechanisms relevant to mitochondrial dysfunction and inherited neurologic disease.

Diabetes and metabolic disease

Trials in type 2 diabetes mellitus examine cardiometabolic risk, including patients without established atherosclerotic cardiovascular disease but with elevated SCORE2-Diabetes risk.

  • Type 2 diabetes mellitus
  • Cardiometabolic risk
  • Atherosclerotic cardiovascular disease

Research interest also includes metabolic inflammation and biomarker changes linked to diabetes-related vascular risk.

Inflammation and vascular biomarkers

Across its studies, the sponsor is engaged in work on inflammatory biomarkers, endothelial biomarkers, and vascular injury in both cardiac and metabolic settings.

  • Inflammatory biomarkers
  • Endothelial biomarkers
  • Vascular injury

This includes interest in mechanisms that connect cardiovascular disease with diabetes and systemic inflammation.

Sponsored Trials

Trial Name Country Status
Efficacy, Safety, and Tolerability of Dimethyl Fumarate in Patients with Friedreich's Ataxia: A Double-Blind, Randomized, Placebo-Controlled TrialItaly ItalyNot Recruiting
Evaluation of Ranolazine for the Prevention of Coronary Microvascular Dysfunction in ST-Elevation Myocardial Infarction with Multivessel DiseaseItaly ItalyRecruiting
Evaluation of Semaglutide on Inflammatory and Endothelial Biomarkers in Type 2 Diabetes Mellitus Patients Without ASCVD or Severe Target Organ DamageItaly ItalyNot Yet Recruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 3 total (0% not shared with other sponsors)

This sponsor works with 3 molecules, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
25%
Return partnership rate
1 of 4 sites collaborated multiple times

This sponsor has worked with 4 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Cardiovascular Diseases1 trial
    359 other sponsors
  • 2.
    Nervous System Diseases1 trial
    449 other sponsors
  • 3.
    Nutritional and Metabolic Diseases1 trial
    211 other sponsors

Partnered Research Centres

4 centres
location_city
assignment43
Azienda Ospedaliera Sant Anna E San Sebastiano Di Caserta
Address
Via Ferdinando Palasciano Snc, 81100 Caserta
Learn morearrow_forward
location_city
assignment560
Azienda Ospedaliera Universitaria Federico II Di Napoli
Address
Via Sergio Pansini 5, 80131 Naples
Learn morearrow_forward
location_city
assignment20
Ospedale Santa Maria Goretti Latina
Address
Viale Michelangelo Buonarroti, 04100 Latina
Learn morearrow_forward
location_city
assignment99
University Magna Graecia Of Catanzaro
Address
Viale Europa, 88100 Catanzaro
Learn morearrow_forward

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Universita' Degli Studi Di Napoli Federico II.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.